Nasdaq:QTI
QT IMAGING HOLDINGS, INC.
QT Imaging Holdings develops AI-powered medical imaging diagnostics, delivering high-value clinical solutions while reporting a net loss of $9.0M in 2024.
Key Metrics
Investment Thesis
Bull Case
Investors may view QT Imaging as a deep-tech play with high potential if its AI-driven products gain widespread adoption in cost-conscious healthcare markets. The company's heavy investment in R&D ($3.3M) suggests a strong pipeline for future product differentiation that could eventually drive margins positive. Recent debt issuance of $10.5M provides necessary runway to survive the current cash burn period.
Bear Case
The stock carries significant downside risk due to a deteriorating financial trajectory with losses expanding from $2.8M in 2022 to $9.0M in 2024. Negative shareholders' equity of $-9.5M and negative cash flow indicate a fragile balance sheet that limits strategic flexibility without further dilution. Investors must weigh the potential for turnaround against the high probability of continued capital raising requirements.
About QT IMAGING HOLDINGS, INC.
QT Imaging Holdings specializes in high-end medical imaging equipment and software solutions, serving hospitals and diagnostic centers globally. The company leverages advanced AI-driven diagnostics to enhance clinical workflows while navigating a challenging macroeconomic environment characterized by shrinking operating cash flows and significant accumulated deficits. With recent revenue of $4.9M in 2024, the firm continues to invest heavily in research and development to maintain its technological edge despite financial headwinds.
Analysis
Management Discussion
The company reported revenue of $4.9M in 2024, yet profitability remains elusive with a net loss widening to $9.0M from $4.0M the prior year. Cash flow from operations turned negative at $10.0M, necessitating significant capital infusions via debt issuance and common share issuances to cover capital expenditures of $87,790.
Industry Overview
The medical imaging sector is transitioning from hardware-centric models to software-defined care, where AI integration creates recurring revenue opportunities but intensifies competition from established giants and agile startups. Regulatory scrutiny on algorithmic transparency in diagnostics remains a critical factor influencing market entry and expansion strategies globally. Consolidation trends favor players with strong cash reserves, putting pressure on smaller firms like QT Imaging to prove sustainable unit economics.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $4.9M |
| Cost of Revenue | $0 | $0 | $2.2M |
| Gross Profit | $0 | $0 | $2.6M |
| Operating Expenses | $4.3M | $4.9M | $14.8M |
| Operating Income | $-4.3M | $-4.9M | $-12.2M |
| R&D | — | — | $3.3M |
| G&A | $4.3M | $4.9M | $11.5M |
| Stock-Based Comp | — | — | $289.8K |
| D&A | — | — | $230.8K |
| Depreciation | — | — | $140.7K |
| Amortization | — | — | $90.1K |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $2.0M | $1.3M | $3.2M |
| Interest Expense | $23.1K | $219.7K | — |
| Interest Income | $1.6M | $1.5M | — |
| Pre-Tax Income | $-2.3M | $-3.6M | $-9.0M |
| Income Tax | $486.6K | $419.1K | $-15.8K |
| Continuing Ops | $-2.8M | $-4.0M | $-9.0M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-2.8M | $-4.0M | $-9.0M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-2.8M | $-4.0M | $-9.0M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $250.7K | $96.4K | $4.9M |
| Accounts Receivable | — | — | $67.1K |
| Inventory | — | — | $3.1M |
| Prepaid Expenses | $172.5K | $94.0K | $516.6K |
| Other Current Assets | $78.2K | $2.4K | $1.2M |
| Long-Term Assets | $41.7M | $23.3M | $1.2M |
| PP&E (Net) | — | — | $195.8K |
| Operating Leases | — | — | $935.2K |
| Other LT Assets | — | — | $39.1K |
| Total Assets | $41.9M | $23.4M | $6.1M |
| Current Liabilities | $4.2M | $12.7M | $9.8M |
| Accounts Payable | $195.1K | $767.6K | $803.3K |
| Current Leases | — | — | $405.7K |
| Deferred Revenue | — | — | $49.4K |
| Other Current Liab | $3.9M | $11.0M | $5.0M |
| Long-Term Liabilities | $9.2M | $8.0K | $5.8M |
| LT Operating Leases | — | — | $657.0K |
| Other LT Liab | — | — | $5.2M |
| Total Liabilities | $13.4M | $12.7M | $15.6M |
| Shareholders' Equity | $28.5M | $10.7M | $-9.5M |
| Paid-In Capital | — | — | $22.4M |
| Retained Earnings | $-13.1M | $-17.1M | $-31.9M |
| Total L&E | $41.9M | $23.4M | $6.1M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-2.8M | $-4.0M | $-9.0M |
| Non-Cash Adjustments | $1.4M | $177.8K | $2.8M |
| Working Capital Changes | $111.5K | $1.9M | $-3.9M |
| Cash from Operations | $-1.3M | $-1.9M | $-10.0M |
| Capital Expenditures | — | — | $87.8K |
| Cash from Investing | $192.2M | $19.9M | $-87.8K |
| Debt Issuances | — | — | $10.5M |
| Debt Repayments | — | — | $1.3M |
| Cash from Financing | $-191.3M | $-18.1M | $11.1M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-343.4K | $-75.8K | $1.0M |
| Beginning Cash | $421.5K | $78.2K | $184.7K |
| Ending Cash | $78.2K | $2.4K | $1.2M |
Frequently Asked Questions
How does QT IMAGING HOLDINGS, INC. make money?
Core revenue stems from the sale and licensing of proprietary medical imaging hardware and software platforms; secondary streams include ongoing service contracts, maintenance agreements, and data analytics subscriptions for healthcare providers.
What are the main risks for QTI?
Severe liquidity constraints evidenced by negative operating cash flow of $10.0M and a substantial accumulated deficit of $31.9M; High sensitivity to healthcare reimbursement cycles and potential delays in regulatory approvals for new AI features; Dependence on continued equity financing as indicated by recent share issuances to offset cash burn.
What is QTI's competitive advantage?
Proprietary artificial intelligence algorithms that significantly reduce false positives in early-stage disease detection; A robust global distribution network with established partnerships in key emerging markets; Continuous innovation pipeline focused on integrating IoT sensors into existing imaging workflows.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.